Xencor (XNCR) Cash & Current Investments (2013 - 2026)

Xencor (XNCR) reported Cash & Current Investments of $74.7 million for Q1 2026, down 82.23% year-over-year from $420.7 million in Q1 2025, and down 55.13% quarter-over-quarter from $166.6 million in Q4 2025.

Xencor (XNCR) Cash & Current Investments (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Cash & Current Investments data on file, last reported at $74.7 million in Q1 2026.

  • Cash & Current Investments for Q1 2026 came in at $74.7 million, down 82.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $74.7 million (down 82.23% YoY), and the FY2025 annual result was $166.6 million, up 87.58% from the prior year.
  • Cash & Current Investments retreated to $74.7 million in Q1 2026 per XNCR's latest filing, from $166.6 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $580.6 million in Q4 2022 and troughed at $74.7 million in Q2 2023.
  • A 5-year average of $324.1 million and a median of $403.4 million in 2025 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2023 and 2024: Cash & Current Investments sank 84.6% in 2023, then surged 542.71% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $580.6 million in 2022, then dropped by 5.01% to $551.5 million in 2023, then tumbled by 83.9% to $88.8 million in 2024, then soared by 87.58% to $166.6 million in 2025, then tumbled by 55.13% to $74.7 million in 2026.
  • Business Quant data shows XNCR's Cash & Current Investments at $74.7 million in Q1 2026, $166.6 million in Q4 2025, and $386.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.13 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.25 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Xencor 953.38 Mn 878.64 Mn - 74.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 74.74 Mn
Dec 31, 2025 166.58 Mn
Sep 30, 2025 386.78 Mn
Jun 30, 2025 403.43 Mn
Mar 31, 2025 420.70 Mn
Dec 31, 2024 88.80 Mn
Sep 30, 2024 464.07 Mn
Jun 30, 2024 480.14 Mn
Mar 31, 2024 75.57 Mn
Dec 31, 2023 551.52 Mn
Sep 30, 2023 465.56 Mn
Jun 30, 2023 74.71 Mn
Mar 31, 2023 112.10 Mn
Dec 31, 2022 580.63 Mn
Sep 30, 2022 568.05 Mn
Jun 30, 2022 485.03 Mn
Mar 31, 2022 111.70 Mn
Dec 31, 2021 180.34 Mn
Sep 30, 2021 88.78 Mn
Jun 30, 2021 161.07 Mn